The Use of Ranolazine for Atrial Fibrillation and Diastolic Heart Failure (RAD HF)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Intermountain Health Care, Inc.
Sponsor:
Collaborator:
Gilead Sciences
Information provided by (Responsible Party):
Intermountain Health Care, Inc.
ClinicalTrials.gov Identifier:
NCT01887353
First received: June 24, 2013
Last updated: February 7, 2014
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2015
  Estimated Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)